Effect of telmisartan on Raf/MEK/ERK single pathway in rats with myocardial hypertrophy
DOI:
CSTR:
Author:
Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective:To investigate the effect of telmisartan on Ras/Raf/ERK1/2 signal pathway in rats with myocardial hypertrophy. Methods:Totally 30 rats were randomly divided into 3 groups including control group,model group and intervention group. Each group has 10 rats. Hypodermic injection of normal saline was applied in control group;hypodermic injection of isoproterenol was ap-plied in model group;hypodermic injection of isoproterenol and telmisartan was applied in intervention group. Myocardial index and pathological detections were performed. RT-PCR assay was used to detect ANP mRNA expression. After the model was successfully made,rats’ left cardiac tissues were collected and p-Raf protein and p-ERK1/2 protein expression was detected by immunohis-tochemistry. Results:Average integral optical density in p-Raf positive area was the highest in model group(P=0.000) followed by intervention group and control group(P=0.041,P=0.031). Average integral optical density in p-ERK1/2 positive area was the highest in model group(P=0.000) followed by intervention group and control group(P=0.0039,P=0.023). Conclusions:Telmisartan resists my-ocardial hypertrophy since it can reduce expressions of Raf protein and ERK1/2 and inhibit the activation of Raf/MEK/ERK signal pathway

    Reference
    Related
    Cited by
Get Citation

QU Chunsheng, CHEN Liping, LI Daolin. Effect of telmisartan on Raf/MEK/ERK single pathway in rats with myocardial hypertrophy[J]. Journal of Chongqing Medical University,2013,(11):1344-1347

Copy
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:
  • Revised:
  • Adopted:
  • Online: September 23,2014
  • Published:
Article QR Code